White matter pathways mediating dorsolateral prefrontal TMS therapy for depression

Area of Science:

• Neuroscience
• Medical Imaging
• Computational Biology

Background:

• Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique used to treat depression.
• The precise neuroanatomical pathways targeted by TMS remain incompletely understood.
• Identifying these pathways is crucial for optimizing treatment efficacy.

Purpose of the Study:

• To map polysynaptic fiber pathways involved in TMS therapy for depression using connectome modeling.
• To investigate the relationship between these pathways and TMS treatment response.
• To determine if pathway length influences the efficacy of functional magnetic resonance imaging-guided TMS.

Main Methods:

• Utilized connectome modeling to reconstruct and analyze brain fiber pathways.
• Identified putative cortical and subcortical routes connecting stimulation sites (dorsolateral prefrontal cortex) to target regions (subgenual cingulate cortex).
• Correlated pathway length with treatment response in two independent patient cohorts undergoing TMS therapy.

Main Results:

• Established specific polysynaptic routes underlying TMS therapy for depression.
• Demonstrated that the length of these brain pathways significantly predicts TMS treatment response.
• Showed that route length is a key factor in the clinical efficacy of fMRI-guided TMS targeting.

Conclusions:

• Connectome modeling provides insights into the neuroanatomical basis of TMS therapy for depression.
• Pathway length is a critical determinant of TMS efficacy, offering a potential biomarker for treatment outcome.
• Findings illuminate the neural circuitry targeted by TMS, guiding future therapeutic strategies.